Additionally, studies focusing on innate immune strategies for activating breast cancer cells and the tumor microenvironment have shown that RIG-I activation within breast tumors enhances tumor-infiltrating lymphocytes while diminishing tumor growth and metastasis (46). Here, RIGI is linked to breast cancer.